{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T03:29:27Z","timestamp":1773372567171,"version":"3.50.1"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Pharmacology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.coph.2025.102584","type":"journal-article","created":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T04:04:12Z","timestamp":1762833852000},"page":"102584","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Redefining remission targets in inflammatory bowel disease: The rise of ultrasound remission"],"prefix":"10.1016","volume":"86","author":[{"given":"Tommaso","family":"Innocenti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armando","family":"Curto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siro","family":"Bagnoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Galli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5752-5113","authenticated-orcid":false,"given":"Gabriele","family":"Dragoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.coph.2025.102584_bib1","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/S0140-6736(23)02586-2","article-title":"Crohn's disease","volume":"403","author":"Dolinger","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.coph.2025.102584_bib2","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(23)00966-2","article-title":"Ulcerative colitis","volume":"402","author":"Le Berre","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.coph.2025.102584_bib3","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1053\/j.gastro.2020.12.031","article-title":"STRIDE-II: an update on the selecting therapeutic targets in inflammatory bowel disease (STRIDE) initiative of the International Organization for the Study of IBD (IOIBD): determining therapeutic goals for treat-to-target strategies in IBD","volume":"160","author":"Turner","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2025.102584_bib4","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1053\/j.gastro.2020.10.065","article-title":"Selecting end points for disease-modification trials in inflammatory bowel disease: the SPIRIT consensus from the IOIBD","volume":"160","author":"Le Berre","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2025.102584_bib5","series-title":"Mucosal healing in inflammatory bowel diseases: a systematic review","author":"Neurath","year":"2012"},{"key":"10.1016\/j.coph.2025.102584_bib6","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1136\/gutjnl-2023-329964","article-title":"Different levels of healing in inflammatory bowel diseases: mucosal, histological, transmural, barrier and complete healing","volume":"72","author":"Neurath","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.coph.2025.102584_sref7","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1053\/j.gastro.2022.10.014","article-title":"Intestinal barrier healing is superior to endoscopic and histologic remission for predicting major adverse outcomes in inflammatory bowel disease: the prospective ERIca trial","volume":"164","author":"Rath","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2025.102584_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.giec.2024.04.001","article-title":"Endoscopy in inflammatory bowel disease: indications, timing, and biopsy protocol","volume":"35","author":"St-Pierre","year":"2025","journal-title":"Gastrointest Endosc Clin N Am"},{"key":"10.1016\/j.coph.2025.102584_bib9","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1365-2036.2011.04710.x","article-title":"Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn's disease","volume":"34","author":"Pan\u00e9s","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.coph.2025.102584_bib10","doi-asserted-by":"crossref","DOI":"10.1093\/ecco-jcc\/jjaf023","article-title":"Assessment of activity and severity of inflammatory bowel disease in cross-sectional imaging techniques: a systematic review","volume":"19","author":"Dal Buono","year":"2025","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.coph.2025.102584_sref11","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102559","article-title":"Ultrasound remission after biologic induction and long-term endoscopic remission in Crohn's disease: a prospective cohort study","volume":"71","author":"Allocca","year":"2024","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.coph.2025.102584_bib12","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.crohns.2011.07.003","article-title":"Results of the 2nd part scientific workshop of the ECCO. II: measures and markers of prediction to achieve, detect, and monitor intestinal healing in inflammatory bowel disease","volume":"5","author":"Daperno","year":"2011","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.coph.2025.102584_bib13","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/ecco-jcc\/jjab106","article-title":"Transmural response and transmural healing defined by intestinal ultrasound: new potential therapeutic targets?","volume":"16","author":"Helwig","year":"2022","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.coph.2025.102584_bib14","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1136\/gutjnl-2018-318081","article-title":"Assessment of Crohn's disease-associated small bowel strictures and fibrosis on cross-sectional imaging: a systematic review","volume":"68","author":"Bettenworth","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.coph.2025.102584_bib15","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S2468-1253(21)00096-0","article-title":"Transmural healing as a therapeutic goal in Crohn's disease: a systematic review","volume":"6","author":"Geyl","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.coph.2025.102584_bib16","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1093\/ecco-jcc\/jjaa098","article-title":"Early transmural response assessed using magnetic resonance imaging could predict sustained clinical remission and prevent bowel damage in patients with Crohn's disease treated with anti-tumour necrosis factor therapy","volume":"14","author":"Messadeg","year":"2020","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.coph.2025.102584_bib17","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s00535-018-1505-8","article-title":"Bowel wall healing assessed using magnetic resonance imaging predicts sustained clinical remission and decreased risk of surgery in Crohn's disease","volume":"54","author":"Buisson","year":"2019","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.coph.2025.102584_bib18","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1007\/s10620-019-05979-8","article-title":"Radiological response is associated with better outcomes and should be considered a therapeutic target in Crohn's disease","volume":"65","author":"Hall\u00e9","year":"2020","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.coph.2025.102584_bib19","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1097\/MIB.0000000000000882","article-title":"Ultrasonographic changes at 12 weeks of Anti-TNF drugs predict 1-year sonographic response and clinical outcome in Crohn's disease: a multicenter study","volume":"22","author":"Ripoll\u00e9s","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.coph.2025.102584_sref20","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.cgh.2024.12.030","article-title":"Intestinal ultrasound findings and their prognostic value in early Crohn\u2019s disease: a copenhagen IBD cohort study","volume":"23","author":"Madsen","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.coph.2025.102584_bib21","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.crohns.2013.01.011","article-title":"Effects of infliximab therapy on transmural lesions as assessed by magnetic resonance enteroclysis in patients with ileal Crohn's disease","volume":"7","author":"Van Assche","year":"2013","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.coph.2025.102584_bib22","doi-asserted-by":"crossref","DOI":"10.1177\/17562848231170947","article-title":"Early transmural healing and its predictors assessed by magnetic resonance enterography in patients with Crohn's disease receiving ustekinumab","volume":"16","author":"Zhou","year":"2023","journal-title":"Therap Adv Gastroenterol"},{"key":"10.1016\/j.coph.2025.102584_bib23","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2147\/CEG.S429039","article-title":"Magnetic resonance enterography assessment of transmural healing with vedolizumab in moderate to severe Crohn's disease: feasibility in the VERSIFY phase 3 clinical trial","volume":"17","author":"Rimola","year":"2024","journal-title":"Clin Exp Gastroenterol"},{"key":"10.1016\/j.coph.2025.102584_bib24","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1093\/ibd\/izae227","article-title":"Improvement of transmural inflammation with adalimumab versus immunomodulator maintenance therapy in pediatric Crohn's disease: single-center prospective evaluation using the pediatric inflammatory crohn's magnetic resonance enterography index","volume":"31","author":"Scarallo","year":"2025","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.coph.2025.102584_bib25","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/apt.16232","article-title":"Transmural healing and MRI healing are associated with lower risk of bowel damage progression than endoscopic mucosal healing in Crohn's disease","volume":"53","author":"Lafeuille","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.coph.2025.102584_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12247569","article-title":"Leaving behind the mucosa: advances and future directions of intestinal ultrasound in ulcerative colitis","volume":"12","author":"Barchi","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.coph.2025.102584_bib27","article-title":"Transmural healing in ulcerative colitis patients improves long-term outcomes compared to endoscopic healing alone","volume":"19","author":"Lim","year":"2025","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.coph.2025.102584_bib28","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1136\/gutjnl-2019-319451","article-title":"Intestinal ultrasound for monitoring therapeutic response in patients with ulcerative colitis: results from the TRUST&UC study","volume":"69","author":"Maaser","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.coph.2025.102584_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/ph18081126","article-title":"Is transmural healing an achievable goal in inflammatory bowel disease?","volume":"18","author":"Faggiani","year":"2025","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.coph.2025.102584_bib30","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1093\/ibd\/izac186","article-title":"Infliximab trough levels are associated with transmural sonographic healing in inflammatory bowel disease","volume":"29","author":"Vaughan","year":"2023","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.coph.2025.102584_bib31","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.gastha.2024.04.007","article-title":"Early sonographic improvement predicts clinical remission and mucosal healing with molecular-targeted drugs in ulcerative colitis","volume":"3","author":"Kimura","year":"2024","journal-title":"Gastro Hep Adv"},{"key":"10.1016\/j.coph.2025.102584_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/ph18050740","article-title":"State-of-the-Art evidence for clinical outcomes and therapeutic implications of Janus kinase inhibitors in moderate-to-severe ulcerative colitis: a narrative review","volume":"18","author":"Choi","year":"2025","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.coph.2025.102584_bib33","doi-asserted-by":"crossref","first-page":"S737","DOI":"10.1093\/ecco-jcc\/jjz202","article-title":"Efficacy of JAK inhibitors in ulcerative colitis","volume":"14","author":"Ferrante","year":"2020","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.coph.2025.102584_bib34","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1093\/ibd\/izaf183","article-title":"Systematic review of available intestinal ultrasound scores for inflammatory bowel disease and update on validation studies","volume":"31","author":"Innocenti","year":"2025","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.coph.2025.102584_sref35","article-title":"Systematic review on definitions of intestinal ultrasound treatment response and remission in inflammatory bowel disease","volume":"19","author":"Allocca","year":"2025","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.coph.2025.102584_sref36","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1002\/ueg2.12671","article-title":"Defining mucosal healing in randomized controlled trials of inflammatory bowel disease: a systematic review and future perspective","volume":"12","author":"Parigi","year":"2024","journal-title":"United European Gastroenterol J"},{"key":"10.1016\/j.coph.2025.102584_bib37","doi-asserted-by":"crossref","first-page":"e723","DOI":"10.1016\/j.cgh.2021.04.029","article-title":"Predictive value of bowel ultrasound in Crohn's disease: a 12-Month prospective study","volume":"20","author":"Allocca","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.coph.2025.102584_sref38","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1093\/ecco-jcc\/jjad068","article-title":"Correlation of ultrasound scores with endoscopic activity in Crohn's disease: a prospective exploratory study","volume":"17","author":"Dragoni","year":"2023","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.coph.2025.102584_bib39","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00330-023-09958-6","article-title":"Diagnostic performance of sonographic activity scores for adult terminal ileal Crohn's disease compared to magnetic resonance and histological reference standards: experience from the METRIC trial","volume":"34","author":"Kumar","year":"2024","journal-title":"Eur Radiol"},{"key":"10.1016\/j.coph.2025.102584_bib40","doi-asserted-by":"crossref","first-page":"8374","DOI":"10.21037\/qims-24-742","article-title":"Validation of intestinal ultrasound scores in assessing endoscopic activity of colonic and small intestinal Crohn's disease in a southwest Chinese cohort: a retrospective cross-sectional study","volume":"14","author":"Zhao","year":"2024","journal-title":"Quant Imag Med Surg"},{"key":"10.1016\/j.coph.2025.102584_bib41","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1093\/ecco-jcc\/jjaa216","article-title":"Expert consensus on optimal acquisition and development of the international bowel ultrasound segmental activity score [IBUS-SAS]: a reliability and inter-rater variability study on intestinal ultrasonography in Crohn's disease","volume":"15","author":"Novak","year":"2021","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.coph.2025.102584_bib42","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/s12876-024-03376-8","article-title":"Different imaging techniques' diagnostic efficacy for Crohn's disease activity and external validation and comparison of MDCTAs, SES-CD and IBUSSAS","volume":"24","author":"Long","year":"2024","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.coph.2025.102584_bib43","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1093\/ibd\/izad251","article-title":"Baseline and postinduction intestinal ultrasound findings predict long-term transmural and mucosal healing in patients with Crohn's disease","volume":"30","author":"Huang","year":"2024","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.coph.2025.102584_bib44","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1093\/ecco-jcc\/jjy107","article-title":"Accuracy of humanitas ultrasound criteria in assessing disease activity and severity in ulcerative colitis: a prospective study","volume":"12","author":"Allocca","year":"2018","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.coph.2025.102584_bib45","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1177\/2050640620980203","article-title":"Milan ultrasound criteria are accurate in assessing disease activity in ulcerative colitis: external validation","volume":"9","author":"Allocca","year":"2021","journal-title":"United European Gastroenterol J"},{"key":"10.1016\/j.coph.2025.102584_bib46","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/ueg2.12206","article-title":"Predictive value of Milan ultrasound criteria in ulcerative colitis: a prospective observational cohort study","volume":"10","author":"Allocca","year":"2022","journal-title":"United European Gastroenterol J"},{"key":"10.1016\/j.coph.2025.102584_sref47","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1093\/ecco-jcc\/jjad071","article-title":"Early intestinal ultrasound predicts long-term endoscopic response to biologics in ulcerative colitis","volume":"17","author":"Allocca","year":"2023","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.coph.2025.102584_sref48","first-page":"169","article-title":"Applicability of the international bowel ultrasound segmental activity score to ulcerative colitis: a preliminary study","volume":"48","author":"Innocenti","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.coph.2025.102584_bib49","doi-asserted-by":"crossref","DOI":"10.1093\/ecco-jcc\/jjaf050","article-title":"The use of international bowel ultrasound segmental activity score (IBUS-SAS) in patients with ulcerative colitis: applicability and comparison with other ultrasound scores","volume":"19","author":"Innocenti","year":"2025","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.coph.2025.102584_bib50","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1002\/ueg2.70053","article-title":"IBUS-SAS is a highly accurate intestinal ultrasound score for predicting endoscopic disease activity in ulcerative colitis","volume":"13","author":"Fischer","year":"2025","journal-title":"United European Gastroenterol J"},{"key":"10.1016\/j.coph.2025.102584_bib51","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/ecco-jcc\/jjab180","article-title":"ECCO-ESGAR topical review on optimizing reporting for cross-sectional imaging in inflammatory bowel disease","volume":"16","author":"Kucharzik","year":"2022","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.coph.2025.102584_bib52","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1159\/000511641","article-title":"Biomarkers of inflammation in inflammatory bowel disease: how long before abandoning single-marker approaches?","volume":"39","author":"Dragoni","year":"2021","journal-title":"Dig Dis"},{"key":"10.1016\/j.coph.2025.102584_bib53","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1093\/ecco-jcc\/jjab051","article-title":"Results of the seventh scientific workshop of ECCO: precision medicine in IBD-What, why, and how","volume":"15","author":"Fiocchi","year":"2021","journal-title":"J Crohns Colitis"}],"container-title":["Current Opinion in Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489225000803?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489225000803?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T17:01:05Z","timestamp":1773334865000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471489225000803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":53,"alternative-id":["S1471489225000803"],"URL":"https:\/\/doi.org\/10.1016\/j.coph.2025.102584","relation":{},"ISSN":["1471-4892"],"issn-type":[{"value":"1471-4892","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Redefining remission targets in inflammatory bowel disease: The rise of ultrasound remission","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coph.2025.102584","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102584"}}